Research Paper Volume 13, Issue 10 pp 13663—13679

The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway

Differences in CENPU expression between breast cancer patients with different clinicopathological features. The clinicopathological features analyzed included (A) age, (B) SBR grade, (C) NPI score, (D) nodal status, (E) ER status, (F) PR status, (G) HER2 status, (H) HU's subtype, (I) RSSPC subtype, (J) basal-like status, (K) triple-negative status, (L) triple-negative and basal-like status.

Figure 2. Differences in CENPU expression between breast cancer patients with different clinicopathological features. The clinicopathological features analyzed included (A) age, (B) SBR grade, (C) NPI score, (D) nodal status, (E) ER status, (F) PR status, (G) HER2 status, (H) HU's subtype, (I) RSSPC subtype, (J) basal-like status, (K) triple-negative status, (L) triple-negative and basal-like status.